Mode
Text Size
Log in / Sign up

Robot-assisted laparoscopic resection provides successful R0 resection for giant pelvic solitary fibrous tumorRobot-assisted surgery treats giant pelvic solitary fibrous tumor

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that robot-assisted laparoscopic resection achieved R0 resection in one case of giant pelvic solitary fibrous tumor.

This case report with literature review describes a single instance of a giant pelvic solitary fibrous tumor (SFT) in a 34-year-old male. The authors synthesize clinical observations regarding the use of robot-assisted laparoscopic resection combined with simultaneous ureteral reimplantation for this specific pathology.

The primary finding is that the surgical approach achieved an R0 resection. Pathology confirmed the diagnosis as STAT6+, CD34+, and Bcl-2+. At 12 months, no complications or recurrences were reported following the procedure.

The authors acknowledge significant limitations, including a small sample size of 1 patient and a short follow-up duration of 12 months. These factors mean that long-term outcomes for SFT are not established by this report.

Clinically, the report suggests robot-assisted laparoscopic surgery as a viable treatment option for patients with giant pelvic SFT. However, due to the low certainty of evidence from a single case, these results should be interpreted with caution regarding broader clinical application.

Imagine living with a massive tumor deep in the pelvis. For a 34-year-old man, this was the reality of a solitary fibrous tumor (SFT). Because of its size and location, traditional surgery can be complex, but a new approach using robot-assisted laparoscopic techniques offered a precise way to remove the growth while repairing nearby structures.

The procedure successfully removed the entire tumor with clear margins. During the same operation, surgeons performed a ureteral reimplantation to ensure proper urinary function. The patient showed no signs of recurrence or complications during the 12-month follow-up period, and pathology confirmed the specific markers associated with this type of tumor.

While this single case shows that robot-assisted surgery is a viable option for large pelvic tumors, it is important to note the limitations. Because this report only follows one patient for one year, we cannot yet know the long-term outcomes or how many years the patient will remain cancer-free.

What this means for you:
Robot-assisted surgery can successfully remove large pelvic solitary fibrous tumors with no complications at 12 months.

Common questions

What is a solitary fibrous tumor?

A solitary fibrous tumor (SFT) is a type of tumor that can occur in various parts of the body. In this specific case, the patient had a giant tumor located in the pelvic region. The surgery confirmed the diagnosis through specific markers like STAT6 and CD34.

Is robot-assisted surgery safe for large tumors?

In this case, the robot-assisted laparoscopic resection was successful. The patient underwent a complete removal of the tumor and a ureteral reimplantation. No complications or adverse events were reported during the 12-month follow-up period.

How long is the follow-up period for this treatment?

The patient was followed for 12 months after surgery. While no recurrence or complications occurred during this time, a 12-month window is considered short-term because these types of tumors can sometimes recur years later.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm with a low incidence, and pelvic SFT is extremely uncommon. Due to its insidious onset and nonspecific imaging features, preoperative diagnosis is difficult. We reported a 34-year-old male patient with a giant pelvic SFT found incidentally during physical examination, complicated with left hydronephrosis and hydroureter. Preoperative imaging revealed a large heterogeneous enhanced mass in the pelvic cavity. Robot-assisted laparoscopic resection of the tumor was performed successfully, accompanied by simultaneous ureteral reimplantation due to severe adhesion between the tumor and the left ureter. The operation was completed with R0 resection. Postoperative pathology and immunohistochemistry (STAT6+, CD34+, Bcl-2+) confirmed the diagnosis of SFT. The patient recovered smoothly and was followed up for 12 months without tumor recurrence or complications. For selected patients with giant pelvic SFT, robot-assisted laparoscopic surgery appears to be a viable treatment option. This technique facilitates meticulous dissection and yields promising short-term clinical outcomes. However, long-term follow-up is required due to the potential for late recurrence of SFT.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.